| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|
| Net loss | -4,554,336 | -1,927,730 | -2,196,875 | |
| Equity dividend to investor | 0 | 10,153,799 | - | |
| Net loss attributable to common stockholders | -4,554,336 | -12,081,529 | - | |
| Earnings per share, basic | -2.02 | -6.79 | -0.05 | |
| Earnings per share, diluted | -2.02 | -6.79 | -0.05 | |
| Weighted average number of shares outstanding, basic | 2,260,068 | 1,780,113 | 44,675,656 | |
| Weighted average number of shares outstanding, diluted | 2,260,068 | 1,780,113 | 44,675,656 | |
HCW Biologics Inc. (HCWB)
HCW Biologics Inc. (HCWB)